title: Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo-β-lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis.
authors.forename: Neil R H
authors.initials: NR
authors.lastname: Stone
authors.forename: Neil
authors.initials: N
authors.lastname: Woodford
authors.forename: David M
authors.initials: DM
authors.lastname: Livermore
authors.forename: Julia
authors.initials: J
authors.lastname: Howard
authors.forename: Rachel
authors.initials: R
authors.lastname: Pike
authors.forename: Shazad
authors.initials: S
authors.lastname: Mushtaq
authors.forename: Claire
authors.initials: C
authors.lastname: Perry
authors.forename: Susan
authors.initials: S
authors.lastname: Hopkins
mesh_terms: D016470:Bacteremia / Q000150:complications / Q000188:drug therapy*; D002115:Calciphylaxis / Q000150:complications / Q000382:microbiology*; D060085:Coinfection; D003091:Colistin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D024881:Drug Resistance, Bacterial; D004926:Escherichia coli / Q000187:drug effects* / Q000201:enzymology; D004927:Escherichia coli Infections / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D007710:Klebsiella Infections / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D007711:Klebsiella pneumoniae / Q000187:drug effects; D008875:Middle Aged; D008911:Minocycline / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D000078304:Tigecycline; D001618:beta-Lactamases / Q000378:metabolism
chemical_list: D000078304:Tigecycline; D001618:beta-Lactamases; C552864:beta-lactamase NDM-1; D008911:Minocycline; D003091:Colistin